MetaCap

Incannex Healthcare Insider Trades

NASDAQ: IXHLHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.86+0.12 (+6.90%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

Incannex Healthcare insider activity

No Incannex Healthcare insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows Valentine Troy (Director) reporting a transaction in 11,302,608 shares on Nov 14, 2025. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put IXHL's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

IXHL insider transactions

Incannex Healthcare insider transactions
DateInsiderTypeSharesValueFiling
Nov 14, 2025Swan JosephCFO, Treasurer and SecretaryAward869,565—Form 4
Nov 14, 2025Widdows PeterDirectorAward1,686,956—Form 4
Nov 14, 2025Clark RobertDirectorAward1,686,956—Form 4
Nov 14, 2025Anastassov GeorgeDirectorAward1,686,956—Form 4
Nov 14, 2025Latham JoelCEO and PresidentAward22,608,692—Form 4
Nov 14, 2025Valentine TroyDirectorAward11,302,608—Form 4
Oct 23, 2024Barbato Luigi M.Chief Medical OfficerAward100,476—Form 4
Dec 21, 2023Widdows PeterDirectorAward100,000—Form 4
Dec 21, 2023Clark RobertDirectorAward100,000—Form 4
Dec 21, 2023Valentine TroyDirectorAward670,000—Form 4
Dec 21, 2023Anastassov GeorgeDirectorAward100,000—Form 4
Dec 21, 2023Latham JoelCEO and PresidentAward1,340,000—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related